Portfolio News
Sofinnova Crossover & Sofinnova Industrial Biotech
Synthace raises £7.3m to accelerate biotechnology to enable faster breakthroughs
Synthace raises £7.3m to accelerate biotechnology to enable faster breakthroughs
Related Company
SynthaceRelated Strategy
CrossoverRelated Strategy
Industrial BiotechRelated Deal lead
Joško BobanovićRelated News
Partnership with French cancer research network FFCD expands Bioptimus’s STELA programme
Moon Surgical and Uncovr Announce First 20 Clinical Cases of Automated Operative Reporting on Maestro®
Mediar Therapeutics Announces First Cohorts Dosed in Phase 1 Clinical Trial of MTX-439 for Fibrosis Associated with Chronic Kidney Disease (CKD) and Additions to Clinical Advisory Board
TISSIUM secures €60 million to support commercial and clinical activities and platform expansion
BrightHeart Announces CE Mark and European Launch of its AI Platform for Prenatal Ultrasound